Dr. Claudine J. Isaacs, Md
Medical Oncology; board certified
Oncology and Molecular Radiation Sciences
George Eliot Hospital NHS Trust, UK
Dr. Claudine Isaacs is the co-director of the Breast Cancer Program and Medical Director of the Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Genomics Research at the Lombardi Comprehensive Cancer Center. Dr. Isaacs' extensive research covers all aspects of breast cancer, including cancer risk assessment, and novel prevention, screening and medical management strategies for women at high risk for breast cancer. Toward that end, she has served as the principal investigator (PI) or co-investigator for numerous clinical trials and grants exploring potential new treatments for early-stage and metastatic breast cancer. Dr. Isaacs also was a PI for the Cancer Genetics Network site and for the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Lombardi was one of 10 sites nationwide that enrolled patients for this trial.
Dr. Isaacs has authored over 185 peer-reviewed publications, numerous book chapters and served as editor for a seminal textbook on hereditary breast cancer, published in 2007. Professionally, she has been a member of the Cancer Education Committee and Scientific Program Committee at the American Society of Cancer Oncology, and the Breast Oncology Local Diseases Task Force of the Breast Steering Committee of the National Cancer Institute, among others. Dr. Isaacs received her medical degree and residency training at McGill University (Canada). She completed fellowship training in the Division of Hematology and Oncology at McGill University and a Fellowship in Breast Medical Oncology in the Division of Medical Oncology at Georgetown University. She then joined the Lombardi faculty in the Department of Medicine (Division of Hematology and Medical Oncology) where she now is also a Professor of Medicine and Oncology.